Webinar Witjes van der Heijden

Feb 16, 2021 | Webinar

What is the place of urinary markers in NMIBC follow-up?

Watch the webinar by Prof. Fred Witjes

On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes, Professor of oncological urology, and 15 minutes Q&A, chaired by Dr. Toine van der Heijden, oncological urologist, both from the Radboud UMC Nijmegen, the Netherlands.

Watch this webinar to learn more about:

  • The current guidelines on treatment and follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC)
  • The pitfalls of the current follow-up procedures
  • Urinary markers in follow-up of NMIBC and promising results from clinical studies
  • Practical considerations about using biomarker tests in clinical practice
Download the free slide resource and brochure
Download the brochure
All updates

Other updates

Urinary biomarkers for the surveillance of NMIBC

Nov 3, 2026 |

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

read more